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Stretching the Law: The Application of Public
Nuisance to the Opioid Epidemic
Lindsay Manning1 and Hannah Thompson2
Opioid use in the United States increased five-fold in the last decade.
Every day ninety Americans die from drug abuse overdose.3 Is it
illegal opioid trafficking, or is it a problem within the medical profession? Recent litigation strategies, like those used in the recent
landmark case of Oklahoma v. Johnson and Johnson, show that opioid production and distribution are being linked to fueling the opioid
epidemic. Oklahoma is just one of the states that have concluded that
Johnson and Johnson, a large pharmaceutical company, is “overstating” the efficiency of opioids and “understating” the harmful effects
of these drugs. Consequently, litigation has begun across the country
charging pharmaceutical companies for causing the opioid crisis.4
This paper will evaluate the legal theories, in particular public nuisance claims, backing the litigation brought against pharmaceutical
companies, as seen in Oklahoma v Johnson and Johnson. However,
it will not attempt to address whether these claims against pharmaceutical companies are right or wrong. Public nuisance is defined differently in each state, a broad definition of public nuisance will be
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applied as stated in the second restatement of torts as “an unreasonable interference with a right common to the general public.”5 This
paper will show that public nuisance claims were never intended
to apply in a widespread public health crisis affecting society as
a whole equally and are therefore not appropriately applied to the
opioid crisis. First, this paper will address the varying outcomes in
public nuisance lawsuits as they have been applied to public health
crises, including the associated controversy that arises from applying public nuisance law. Second, this article will argue that the rulings found in recent opioid trials have incorrectly applied the law
of public nuisance to the opioid crisis. Finally, this paper will argue
that determinations of liability for public health crises, in particular
the opioid crisis, should be defined using alternative legal remedies,
namely master settlement agreements, legislation, and toxic torts.
Through these proposed remedies, public health crises can be properly litigated.

I. Background
Public nuisance has its origins in property and criminal law. Until
the 1970s, public nuisance claims were exclusive to property nuisance, generally requiring a special injury to the individual beyond
that of the general public. We define property nuisance as an action
taken on a landowner’s own property or the property of another
which affects the health or safety or either an individual or the public
at large. Furthermore, the requirement for special injury asserts the
plaintiff must show the nuisance provided injury to himself beyond
that of the general public. Subsequent precedent set limits to the
vague language surrounding public nuisance, thus providing a way
for judges to assess the validity of public nuisance claims. 6
However, in the 1970s arguments arose for public nuisance
law to be applied to a wider range of environmental and social
problems. Advocates for this change realized the vague language of
5
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the public nuisance law and its possible application to wide-spread
health issues. In the second restatement of torts, written in 1972,
public nuisance was included, being described simply as “an unreasonable interference with a right common to the general public …
whether the conduct involves a significant interference with the public health, the public safety, the public peace, the public comfort,
or the public convenience.” 7 With this more open interpretation of
public nuisance describing it as a tort, claims arose over the next
four decades seeking damages for social issues such as pollution,
lead paint, asbestos, and tobacco. Over the course of the 80s, 90s,
and 2000s, the majority of public nuisance claims pertaining to public health issues were dismissed by the state court of appeals and
deemed an inappropriate application of the law because of an established precedent requiring a property nuisance and special injury
to an individual beyond that of the general public, thus making the
cases of large public health crises inapplicable.8
However, the recent success in applying public nuisance law
to the nation’s ongoing opioid crisis in Oklahoma v Johnson and
Johnson has revitalized the debate surrounding the interpretation of
public nuisance. Johnson and Johnson were required to pay damages totaling more than 500 million dollars for their involvement in
fueling the nation’s opioid crisis by marketing potentially harmful
drugs. Their actions were viewed as interfering with a right common to the general public and thus a public nuisance.9 Since politicians and commentators are now calling the opioid epidemic the
most prevalent public health crisis of our day, public nuisance claims
are again begin brought to the forefront of opioid litigation. This
is perhaps due to the lack of response from legislative bodies and
the fact that up to this point no regulations have kept pharmaceutical companies from engaging in aggressive marketing tactics. This
paper argues that if the current application of public nuisance law
were to continue, it would become a “catch-all” law for issues not
7
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being addressed fast enough by the legislative bodies or where other
applications have failed. However, as the precedent shows, courts are
generally reluctant to accept this new application. The following sections will address the major public nuisance cases brought in varying public health crises, why they were either dismissed or accepted,
and what remedies would have worked instead. This analysis will
then be applied to the current opioid crisis to evaluate the similarities
and differences between the preceding litigation.

II. Application of Public Nuisance
In 1971, a California district court litigated one of the first public
nuisance claims since the second restatement of torts, Diamond v.
General Motors. The plaintiffs, composed of seven million individuals, accused 293 industrial organizations of committing public nuisance for emitting and discharging pollution into the air surrounding
the Los Angeles valley. Because the automobiles emitted harmful substances simply from its intended use, the plaintiffs argued
that the organizations willfully and maliciously harmed the environment and the health of the general public. The defendants were
also accused of being negligent in their manufacturing and sale of
automobiles. Accordingly, the plaintiffs sought billions of dollars in
damages, as well as an injunction restraining the sale and standards
of future automobiles in the Los Angeles County.10
The court dismissed this claim for several reasons. First, the
court rejected the idea that this case was a class action, meaning
seven million individuals is too many for a legitimate lawsuit. Second, the court maintained that a private claim required that the public nuisance cause special injury to himself. This meant that each
of the seven million plaintiffs would have to show special injury
from the pollution. The court cited California Civil Code Section 3493
which provides: “A private person may maintain an action for a public
nuisance, if it is especially injurious to himself, but not otherwise.”11
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Finally, the California state court saw the issue of pollution in the
Los Angeles valley better left to the legislature.
This case showed the evolving view of some that the judiciary
should be allowed to decide on matters of public policy. It also
showed how reluctant courts are to take on this role. In Diamond
v. General Motors the court did not think that it was appropriate to
solve the problem of pollution in the Los Angeles valley. While
some argue that the court should be more responsible for public
policy due to the corruption, lobbying, and ineffectiveness from
legislative bodies, in this situation the court did not think public
nuisance was a valid claim to enact these changes.
Despite the reaction of the California state court to a public nuisance claim for a public health crisis, litigation continued against
companies seen to be polluting the atmosphere and harming individuals. The new wording of public nuisance law seemed to extend
the scope of its application to include all forms of actions hurting
a community’s public health. Although, in most states the courts
rejected these attempts, there are still some cases that have succeeded in using public nuisance law to regulate corporations. In
State v. Schenectady Chemicals, the state of New York charged the
owner of a chemical waste disposal with improperly disposing of
the waste, thus being charged for the subsequent damages done to
the soil and local water supply. The courts proclaimed: “We do not
hesitate in recognizing the seepage of chemical wastes into a public
water supply constitutes a public nuisance . . . the attorney general
is clearly authorized on behalf of the state to commence legal proceedings to abate a public nuisance.” 12
While this appears to be a success for the new definition of
public nuisance, there are some key differences between the decisions made in Schenectady and General Motors is that in New York.
Most importantly is that the courts also cited public policy enacted
by legislature determining the actions of the chemical waste site to
be illegal prior to the action taking place. Alternatively, in General
Motors the existing regulations did not criminalize those actions of
the industrial organizations. The latter is analogous to the current
12
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opioid situation. Legislation concerning the regulation of opioid
drug manufacturers is not as widespread as pollution regulations.
In Johnson and Johnson, the defendants argue that their practices
in marketing, advertising, and selling their opioid medicines were
all in accordance to the national and state regulations at that time.13
Therefore, similar to California pollution nuisance claims, it is
inappropriate for courts to make public policy based on public nuisance claims. Regardless of the actions taken by pharmaceutical
companies, public nuisance cannot become a “catch-all” for perceived wrongs not yet regulated by the government. The federal
and state government have already created laws for companies producing harmful products through the use of toxic torts. Toxic torts
will be discussed in-depth further in this paper, however, they are
the current regulations binding producers. If pharmaceutical companies had violated these laws then litigation would be appropriate.
However, public nuisance cannot fill the gaps of toxic torts.
B. Lead Paint
The ongoing litigation of the toxicity of lead paint has been at the
front of research. Initial litigation failed to hold the paint companies liable in the 1950’s because all regulations that were held by the
FDA were being followed, yet the debate has continued. Recently
decisions by the state courts in California have found several paint
companies liable for public nuisance in the distribution of lead paint
in past years, regardless of failed past attempts to apply public nuisance. The FDA laws now applying to lead paint have been updated,
and the companies are to pay hundreds of millions of dollars into an
“abatement” fund to investigate residential lead paint in the state’s
ten most populous counties and remediate any dangerous conditions
found there. The companies sold the paint legally, because the paint
was following all federal regulations at the time. 14
This application of public nuisance can be misleading because
the companies are not being held liable for the actual manufacturing
13
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or selling of the dangerous products, yet they are being held liable
for the marketing of the paint, despite the fact that the paint was in
accordance with regulations at the time. This can be misleading as
to what we view as harmful to consumers. As seen from the result
of the case marketing and advertising are the issues of safety and
not lead paint. The banning of lead paint was not put into action
until 1978, and the company was following all regulations that they
were aware of prior to this period. “With its ruling, the California Superior Court became the first and only jurisdiction to accept
a product-based public nuisance theory against lead-based paint
manufacturers” 15
This is similar to the ongoing opioid crisis, specifically to the
recent case of Johnson & Johnson v. Oklahoma, where a company
was abiding all FDA regulations. Yet, it was held liable as a public
nuisance due to its “aggressive marketing” (as stated by the New
York Times) to doctors, and for not properly informing consumers of side effects.16 Public nuisance claims should not concern
themselves with consumer use of a product. The Institute of Legal
Reform explains why consumer use is not viable under public nuisance theory; “Allowing what is essentially a claim about a defective product to go forward under a public nuisance theory presents
difficult issues of proof regarding causation and redressability.”17
As they were following all regulations that they were aware of,
toxic torts would be the appropriate application. Toxic torts refer
to the actual harm that the product caused to the consumer, which
would be more applicable than their attempt to use public nuisance
through their marketing of opioids. Overall, opioids are the root
problem that harms consumers, and which the state is seeking help
15
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and assistance for. By targeting the marketing, the root of the problem is not addressed; whereas, a toxic tort would encompass the opioids and the consumer misuse. This remedy is not used due to the
specificity needed for a toxic tort claim.
C. Tobacco
While litigants continually bring cases against the tobacco industry, few of those are public nuisance claims. Of these claims made
against tobacco companies most were dismissed by the courts due
to pending settlement agreements or inapplicability of the law. The
legal theories surrounding the tobacco litigation are perhaps the most
similar to that of the current opioid litigation due to its significant
stretch from the previous standards of special injury and nuisance to
a property. With pollution, lead paint, and asbestos litigation, there
is a claim for injury to property. However, with the manufacturing of
cigarettes or opioid litigation, there is no claim of a misuse of property
as the common law states is necessary for a public nuisance action.
In the 1997 case Texas v. American Tobacco Company, a count
of public nuisance was brought against the American Tobacco Company. The state claimed, similar to the argument in the opioid litigation Johnson & Johnson v. Oklahoma, that the “defendants have
intentionally interfered with the public’s right to be free from unwarranted injury, disease, and sickness and have caused damage to the
public health, the public safety, and the general welfare of the citizens of the State of Texas.” 18 The courts dismissed this claim outright, citing Texas public nuisance law as “the use of any place for
certain, specific prescribed activities such as gambling, prostitution,
and the manufacture of obscene materials.”19 This definition of public nuisance law is similar to statutes from other states by including
a property nuisance. The defendants argued that since there was no
misuse of property, there could be no claim of public nuisance.
The Texas state court said, “The State has not pled a proper
claim, because it has failed to plead essential allegations under Texas
18

Texas v. Am. Tobacco Co., 14 F. Supp. 2d 956, 973 (E.D. Tex. 1997).

19

Id. at 973.

Stretching the Law:
The Application of Public Nuisance to the Opioid Epidemic

145

public nuisance law. Specifically, the State failed to plead that Defendants improperly used their own property, or that the State itself has
been injured in its use or employment of its property.” Therefore,
this specific count of public nuisance was dismissed. The Texas
State Court had one final note in saying, “The overly broad definition of the elements of public nuisance urged by the State is simply
not found in Texas case law and the Court is unwilling to accept the
state’s invitation to expand a claim for public nuisance beyond its
ground in real property.”20 This response is similar to the responses
we have seen in other public health issues: the courts are reluctant to
broaden the definition of public nuisance law.

III. Legal Remedies
A. Master Settlement Agreement
Before public nuisance claims could be brought against tobacco
companies on a large scale, a settlement agreement was reached.
The Master Settlement Agreement, reached in November, 1998,
included forty-six states and five of the largest tobacco manufacturers in the U.S. It included payments of billions of dollars to the states
to mitigate the damage done by tobacco products.21 Furthermore,
injunctions were handed down to limit the extent to which tobacco
companies could advertise, market, and promote their products.
Tobacco companies engaged in the settlement agreement to end
the immense costs of future litigation that could have occurred.
And while sceptics criticized the allocation of the money from this
settlement, claiming that it hadn’t actually been spent on alleviating the health problems caused by tobacco, the Master Settlements
Agreement was successful in ending the large amount of litigation
facing tobacco companies.
20
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The option of a master settlement agreement may be appealing
to the pharmaceutical companies now facing large amounts of litigation for the opioid crisis. As shown in the preceding paragraphs, the
route of public nuisance claims has been unreceptive by the courts. It
is unclear if the opioid litigation will find success in using public nuisance claims against drug manufacturers. Therefore, a master settlement agreement, similar in nature to that of the tobacco settlement,
could be a good course of action for states and pharmaceutical companies wishing to end the litigation and establish liability for the opioid epidemic. A settlement agreeing to a fixed amount of reparations
and injunctions pertaining to the marketing and advertising of these
addictive drugs would be in the best interest of both parties as the
unpredictability of future litigation is not desirable for the companies.
Potential objections to a master settlements agreement could
come from the misallocation of damages received. In the tobacco
settlement, many argue that the funds never reached those whose
health was affected. Similarly, damages received from the opioid
settlement may never be used to fund drug rehabilitation efforts.
Furthermore, A master settlement agreement may seem undesirable to pharmaceutical companies because they believe they are in
the position to win the litigation against them. However, the recent
decision of Oklahoma v. Johnson & Johnson shows that the confusing nature of public nuisance law does not guarantee success in any
state. If the courts continue to pursue and allow public nuisance
claims, it would open the way for each individual court to decide
a new definition of public nuisance despite the standing of special
injury and property. Therefore, we argue that a better course of
action would be to engage in a master settlement agreement.
B. Legislation
Another option would be for legislation to be made creating clearer
and stricter regulations for pharmaceutical companies. The reason
activists are pushing to broaden the definition of public nuisance is
their dissatisfaction with the decisions made by the legislature. For
example, in the cases against pollution, litigants were dissatisfied
with how relaxed the standards were for emitting pollutants into
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the air as well as how slow the legislative branch was at making
changes. Similar complaints will be made about any opioid litigation; however, it would be more beneficial for statutes to be made
setting clear standards of marketing operations, rather than relying
on public nuisance claims. Similar to the case, State v. Schenectady Chemicals, public nuisance claims could be brought within the
bounds of a state or federal statute. The aforementioned case cited
heavily from the Resource Conservation and Recovery Act of 1976,
and therefore showed that what those companies were doing was
illegal.22 States, however, would probably be reluctant to accept this
legal theory because it would mean a violation of due process if they
attempted to continue the litigation against pharmaceutical companies. Legislation is necessary if clear standards want to be made as to
what practices of opioid drug manufacturers are illegal. Public nuisance will continue to provide only vague and confusing results that
vary significantly across the nation and within states. If the judicial
branch wants to ascertain judgement against pharmaceutical companies, it must be done within the context of a specific statute or law.
C. Toxic Torts
We also propose that these cases (i.e.: lead paint, opioids, etc.) be
tried within the scope of a toxic tort rather than public nuisance.
When the public nuisance attacks the marketing of a product, a toxic
tort brings us back to the original problem, the product. A toxic tort
is “… a legal claim for harm caused by exposure to a dangerous substance—such as a pharmaceutical drug, pesticide, or chemical.”23
However, many people steer away from the application of a toxic
tort because of the additional statement within the law that implies
“In a toxic tort claim, the plaintiff (the person who sues) alleges that
exposure to some dangerous substance caused an injury or illness.”24
Many people will avoid this application because a tort is seen as
22
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personal injury, and people find it difficult to sue large companies as
an individual. The workload of addressing every individual involved
within the scope of the respective health crisis is one that simply
cannot be taken on without reform. But, the application of the law,
and the solution will remain in addressing the problem in which we
originally set out to correct.

IV. Current Opioid Litigation
A. Johnson & Johnson v. Oklahoma
The controversy of public nuisance is applicable more than ever due
to the recent case of Johnson & Johnson v. Oklahoma. The pharmaceutical company was originally sued for 17 billion dollars in
order to provide twenty years of rehabilitation funding for victims
of opioid addiction. The State of Oklahoma decided that the company would instead payout 572 million dollars which would cover
approximately one year of rehabilitation for those affected by the
opioid health crisis.25 There are now approximately 2,000 additional
pending cases seeking to employ similar legal strategies. The state
had priority settled with other pharmaceutical companies (Purdue
and Teva.), which resulted in sole responsibility lying on just one
company, Johnson & Johnson. 26
The verdict was determined under a public nuisance law and
was targeted at the marketing of the drug to doctors, without appropriately relaying the side effects of the products to the doctors. This
interpretation is made off of vague statements within the law pertaining to public nuisance. Aggressive marketing of drugs is not illegal under any FDA regulations of federal statutes as of yet. Johnson
25
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& Johnson was following all FDA regulations with the drugs it was
making. Ultimately, the problem is consumer abuse of opioids not
Johnson & Johnson’s marketing of products. Therefore, claiming
that the companies marketing is a public nuisance does not address
the root problem of opioid addiction. The state of Oklahoma chose to
apply a law that did not alter the actual misuse of opioids, which are
claimed to be addictive and harming to their state population. The
actual public nuisance is the distribution and individual misuse of
opioids, not the initial pharmaceutical market of the product.

V. Conclusion
The opioid crisis is complex, but that cannot be the reason that it continues to go unaddressed. There is a need for better applications to
solve the current epidemic. A public nuisance argument is inappropriate and ineffective in dealing with the seriousness of this nation’s
health crisis. With proposed solutions of applying toxic torts, master
settlement agreements, and legislation to the nation’s health crisis,
we argue the following benefits: safer pharmaceutical products with
more cautious responsibility for providers, standard regulations for
all parties involved of the creating and distribution of products, and
concise laws applying to our nation’s health crisis. This country
should protect health and well-being of its citizens, and if opioids are
a problem, litigation should focus on the individuals and the specific
negative effects of opioids. Public nuisance should only be applied
when it does not have to be contorted to fit an argument and allow all
the laws to uphold the best interest of the public.

